Copyright © 2001 by the European Society of Cardiology.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Letters to the Editor
A reply
Internal Medicine III (Cardiology/angiology), University of Saarland, D 66421, Homburg/Saar, Germany
References
- Davidson CJ, Laskey WK, Hermiller JB. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation. 2000;101:2172–2177
[Abstract/Free Full Text] - Hay K, Bull S. An analysis of platelet activation and aggregation produced by three classes of contrast media. JVIR. 1995;6:211–217[ISI][Medline]
- Scheller B, Heib KD, Müller M, Hennen B, Özbek C, Schieffer H. Röntgenkontrastmittel in der invasiven Kardiologie, Nebenwirkungen und differenzierter Einsatz. Z Kardiol. 1998;87:545–552[CrossRef][ISI][Medline]
- Sutton A, Finn P, Grech E. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am Heart J. 2001;141:677–683[CrossRef][ISI][Medline]
- Schräder R, Esch I, Ensslen R. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (ioxaglatee) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. J Am Coll Cardiol. 1999;33:395–402
[Abstract/Free Full Text] - Heptinstall S, White A, Edwards N. Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice? Br J Haematol. 1998;103:1023–1030[CrossRef][ISI][Medline]
- Markou CP, Chronos NA, Hanson SR. Antithrombotic effects of ionic and nonionic contrast media in nonhuman primates. Thromb Haemost. 2001;85:488–493[ISI][Medline]
- Bertrand ME, Esplugas E, Piessens J, Rasch W. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty VIP Trial Investigators. Circulation. 2000;101:131–136
[Abstract/Free Full Text] - Scheller B, Hennen B, Thünenkötter T, Mrowietz C, Markwirth T, Schieffer H, Jung F. Influence of X-ray contrast media on rheological properties after coronary angiography. Thromb Res. 1999;96:253–260[CrossRef][ISI][Medline]
- Grabowski E, Rodriguez M, McDonnell S. Platelet adhesion/aggregation in an in vitro model of coronary artery stenosis. Cath Cardiovasc Diagn. 1993;28:65–71[ISI][Medline]
- Arora R, Khandelwal M, Gopal A. In vivo effects of nonionic and ionic contrast media on beta-thromboglobulin and fibrinopeptide levels. J Am Coll Cardiol. 1991;17:1533–1536[Abstract]
- Davidson CJ, Mark DB, Pieper KS. Thrombotic and cardiovascular complications related to nonionic contrast media during cardiac catheterization: analysis of 8,517 patients. Am J Cardiol. 1990;65:1481–1484[CrossRef][ISI][Medline]
- Gasperetti CM, Gonias SL, Gimple LW, Powers ER. Platelet activation during coronary angioplasty in humans. Circulation. 1993;88:2728–2734
[Abstract/Free Full Text] - Gawaz M, Neumann FJ, Schomig A. Evaluation of platelet membrane glycoproteins in coronary artery disease: consequences for diagnosis and therapy. Circulation. 1999;99:E1–E11
- Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I, Morooka S. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris. Am J Cardiol. 2000;86:1057–1062[CrossRef][ISI][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Scheller A reply Eur. Heart J., January 2, 2002; 23(2): 173 - 175. [Full Text] [PDF]
|
|
|
|
|
|
B. Scheller A reply Eur. Heart J., November 1, 2001; 22(21): 2028 - 2029. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||